Descriptive study title
Published 2020
Study Design
- Population
- n, who, inclusion/exclusion (1–2 lines)
- Design
- Randomized, double-blind, placebo-controlled
- Dosage
- 500 mg/day (standardized to X%)
- Duration
- 8 weeks
Citation
Journal Name (2020).
Authors: First Last
Affiliation: Lab / Institution
Plain takeaway
One-liner for lay readers.
Methods & Controls
Key collection methods and instruments…
Controls: Placebo / active control, blinding, randomization…
Key outcomes
- CRP — ↓ vs placebo — 32% average reduction
- Pain score (WOMAC) — improved vs placebo
Summary & Interpretation
3–5 sentence narrative: what was tested, who, what changed, how big, safety, caveats.
Funding & Conflicts
Funding: Sponsor / grant
Conflicts: Any COI disclosed